On September 6, 2023 Aprea Therapeutics, Inc. (Nasdaq: APRE) ("Aprea" or the "Company"), a clinical stage biopharmaceutical company focused on precision oncology through synthetic lethality, reported that Oren Gilad, Ph.D., President and Chief Executive Officer, will present a corporate overview at the H.C. Wainwright 25th Annual Global Investment Conference, which is scheduled to take place on September 11-13, 2023 in New York, NY (Press release, Aprea, SEP 6, 2023, View Source [SID1234634934]). Management will also be available for one-on-one meetings. Details are as follows:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright 25th Annual Global Investment Conference
Date: Monday, September 11, 2023
Time: 4:30 pm ET
Location: New York, NY and virtual
Registration Link: Click HERE

The webcast will also be available for viewing and replay on the "News and Events" tab of the Company’s website (www.aprea.com). A replay of the webcast will be archived on the Company’s website for 90 days following the presentation.

On September 6, 2023 Alentis Therapeutics ("Alentis"), a clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis, reported two company presentations at investor conferences in September and October (Press release, Alentis Therapeutics, SEP 6, 2023, View Source [SID1234634933]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

UBS Biotechnology Private Company Virtual Symposium
The virtual conference is to be held September 20-21, 2023. Roberto Iacone, Chief Executive Officer of Alentis will participate in a fireside chat on Thursday, September 21 at 8:30 am ET.

Oppenheimer Private Healthcare Company Showcase
The conference is to be held October 11, 2023 at The Intercontinental New York Barclay Hotel. Roberto Iacone will give a company presentation at 9:00 am ET in Track 1.

On September 6, 2023 AbbVie (NYSE: ABBV) reported that it will participate in the Morgan Stanley 21st Annual Global Healthcare Conference on Wednesday, September 13, 2023 (Press release, AbbVie, SEP 6, 2023, View Source [SID1234634932]). Robert A. Michael, president and chief operating officer, Scott Reents, executive vice president, chief financial officer, Jeffrey R. Stewart, executive vice president, chief commercial officer and Roopal Thakkar, senior vice president, development and regulatory affairs and chief medical officer, will present at 9:50 a.m. Central time.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio webcast of the presentation will be accessible through AbbVie’s Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

On September 6, 2023 2seventy bio, Inc. (Nasdaq: TSVT), a leading immune-oncology cell therapy company, reported that members of the management team will participate in a fireside chat at the upcoming 2023 Morgan Stanley Global Healthcare Conference on September 13, 2023 at 3:35pm ET in New York (Press release, 2seventy bio, SEP 6, 2023, View Source [SID1234634931]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast will be available via the Investors and Media section of 2seventy bio’s website at View Source A replay will be archived on 2seventy bio’s site for 30 days following the event.

On September 6, 2023 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep" or "the Company"), a clinical-stage biotechnology company developing novel LAG-3 immunotherapiesfor cancer and autoimmune disease, reported that its management will participate in the following upcoming investor conferences in September (Press release, Immutep, SEP 6, 2023, View Source [SID1234634915]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

• The 18th Annual Citi Biopharma Conference in Boston, MA on Thursday, September 7.
• Bell Potter Emerging Ideas Leaders Conference on September 12. Presentation at 3:30 p.m. AEST.
• Baird’s 2023 Global Healthcare Conference in New York City, NY on September 12. Fireside chat at 3:45 p.m. ET.
• E&P Small Cap Healthcare Conference in Sydney, NSW. Presentation on September 13 at 4:25 p.m. AEST.
• 2023 Cantor Global Healthcare Conference in New York City, NY on September 26.

Panel presentation at 2:45 p.m. ET. Further information about upcoming conferences and events that Immutep’s management will be attending is available at the Events page within the Investors & Media section of Immutep’s website.